Tai Odiase

CC
Hapoel IBI Tel Aviv
GTD
Injury Undisclosed
Est. Return 3/19/2026
Injured in training
CHapoel IBI Tel Aviv
Undisclosed
March 19, 2026
Odiase is dealing with an unspecified injury and is uncertain for Thursday's game against Virtus Bologna, according to Noa Poplinger of Sport5.
ANALYSIS
Odiase was injured during Thursday's pregame shootaround, and he could miss Round 32. Another update on his status will be posted when it is announced whether or not he will suit up Thursday.
Read More News
EuroLeague Per Game Stats
Per Game
Total
Per 36
EuroLeague Per Game Stats
Loading Per Game Stats...
EuroLeague Total Stats
Loading Total Stats...
EuroLeague Per 36 Stats
Loading Per 36 Stats...
Game Log
2025
Game Log
Calculate Stats Over Time
Just click on any two dates.
Scoring
DraftKings
Dream11
Loading Game Log...
Advanced Stats
Loading Advanced Stats...
Hapoel IBI Tel Aviv Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
More Fantasy News
Takes court Sunday
CHapoel IBI Tel Aviv
December 14, 2025
Odiase (ankle) started and tallied 18 points and two steals over 21 minutes in Sunday's domestic contest.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Takes seat again
CHapoel IBI Tel Aviv
Ankle
December 13, 2025
Odiase (ankle) did not play in Friday's victory over Virtus Bologna.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Suiting up Friday
CHapoel IBI Tel Aviv
December 12, 2025
Odiase (ankle) will be available for Friday's game against Virtus Bologna, according to Hapoel Tel Aviv's official X account.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
No minutes Thursday
CHapoel IBI Tel Aviv
Ankle
December 4, 2025
Odiase (ankle) did not play in Thursday's victory over ASVEL.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Overcomes injury
CHapoel IBI Tel Aviv
December 4, 2025
Odiase (ankle) will be available for Thursday's game against ASVEL, according to Hapoel Tel Aviv's official X account.
ANALYSIS
Subscribe now to instantly reveal our take on this news.